Prescription Patterns of Sodium-glucose Cotransporter-2 Inhibitors in Adults With Type 2 Diabetes and Heart Failure With Reduced Ejection Fracture Admitted to a Tertiary Care Centre in Ontario, Canada
Open Access
- 4 July 2024
- journal article
- research article
- Published by Elsevier in Canadian Journal of Diabetes
- Vol. 48 (7)
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Contemporary Use of Sodium-Glucose Cotransporter-2 Inhibitor Therapy Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction in the USJAMA Cardiology, 2023
- Patterns and Patients’ Characteristics Associated With Use of Sodium-Glucose Cotransporter-2 Inhibitors Among Adults With Type 2 Diabetes: A Population-based Cohort StudyCanadian Journal of Diabetes, 2022
- New Diabetes Guidelines: Impact on Eligibility for Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in CanadaCanadian Journal of Diabetes, 2022
- The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trialNature Medicine, 2022
- Patterns of Prescribing Sodium-Glucose Cotransporter-2 Inhibitors for Medicare Beneficiaries in the United StatesCirculation: Cardiovascular Quality and Outcomes, 2021
- SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: A systematic review and meta-analysiseClinicalMedicine, 2021
- CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection FractionCanadian Journal of Cardiology, 2021
- Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 DiabetesJAMA Cardiology, 2021
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart FailureNew England Journal of Medicine, 2021
- SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trialsThe Lancet, 2020